Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?
- 8 January 2021
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 394 (5) , 997-1001
Abstract
Chloroquine and hydroxychloroquine belong to the aminoquinoline drugs. Studies revealed that chloroquine and hydroxychloroquine shows antagonism activity against COVID-19 under laboratory conditions. ARDS and ALI are conditions that occur in patients with COVID-19 as the main pathological complications of cytokine storm. Inflammasomes play a key role in the pathogenesis of many diseases associated with destructive inflammation. NLRP3 inflammasome has been shown to play a key role in the pathogenesis of viral diseases. The possible role of NLRP3 inflammasome inhibitors in the treatment of COVID-19 has been considered. We surveyed the potential inhibitory effect of chloroquine and hydroxychloroquine on inflammasome. Studies indicate that one of the possible anti-inflammatory mechanisms of chloroquine and hydroxychloroquine is inhibition of the activity of NLRP3 inflammasome.Keywords
This publication has 31 references indexed in Scilit:
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 2017
- Inflammasomes and its importance in viral infectionsImmunologic Research, 2016
- Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasomeScientific Reports, 2016
- Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activationScientific Reports, 2015
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome ActivationImmunity, 2013
- The Biological and Clinical Activity of Anti-Malarial Drugs In Autoimmune DisordersCurrent Rheumatology Reviews, 2013
- Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1βNature Immunology, 2012
- Chloroquine and Hydroxychloroquine ToxicityArchives of Ophthalmology (1950), 2011
- Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor‐expressing cells: implications for its therapeutic actionBritish Journal of Pharmacology, 2011
- HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells.1999